What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies
Authors:
- 19 May 2015
- journal article
- review article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 87 (3) , 319-323
Abstract
The term SWEDD (scans without evidence for dopaminergic deficit) refers to the absence, rather than the presence, of an imaging abnormality in patients clinically presumed to have Parkinson's disease (PD). However, such a term has since been widely used in the medical literature, even as a diagnostic label. While many authors have suggested that different disorders of PD lookalikes may account for a proportion of SWEDD cases, others have claimed that some of them may have a benign subtype of PD. Thus, there has been ensuing controversy and confusion and the use of this term continues without clarity of what it represents. We have systematically reviewed all the studies involving patients with SWEDD with the aim of shedding light on what these patients actually have. It becomes clear from this systematic review that while most ‘SWEDD’ cases are due to a clinical misdiagnosis of PD, there exists a small proportion of patients with SWEDD who may have PD on the basis of a positive levodopa response, clinical progression, imaging and/or genetic evidence. The latter challenge the seemingly incontrovertible relationship between dopaminergic tracer binding and the diagnosis of nigrostriatal parkinsonism, particularly PD. Patients with SWEDD are unlikely to reflect a single clinical entity and we suggest that the term SWEDD should be abandoned.Keywords
This publication has 74 references indexed in Scilit:
- Longitudinal follow-up of SWEDD subjects in the PRECEPT StudyNeurology, 2014
- The Parkinson Progression Marker Initiative (PPMI)Progress in Neurobiology, 2011
- Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: A clinical and electrophysiological studyMovement Disorders, 2010
- Scans without evidence of dopamine deficiency: The triumph of careful clinical assessmentMovement Disorders, 2010
- Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson diseaseNeurology, 2007
- Patients with adult‐onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs)Movement Disorders, 2007
- Levodopa and the Progression of Parkinson's DiseaseNew England Journal of Medicine, 2004
- Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET studyAnnals of Neurology, 2003
- Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: Part 1. Baseline and 3‐month observationsMovement Disorders, 2003
- Dopamine Transporter Brain Imaging to Assess the Effects of Pramipexole vs Levodopa on Parkinson Disease ProgressionJAMA, 2002